| Name | Value |
|---|---|
| Revenues | 354.7M |
| Cost of Revenue | 114.3M |
| Gross Profit | 240.4M |
| Operating Expense | 191.6M |
| Operating I/L | 48.8M |
| Other Income/Expense | 3.5M |
| Interest Income | 4.4M |
| Pretax | 52.3M |
| Income Tax Expense | 6.5M |
| Net Income/Loss | 45.9M |
Penumbra, Inc. is a global medical device company specializing in the design, development, manufacturing, and marketing of a wide range of neurovascular and vascular medical devices. The company's product portfolio includes aspiration-based thrombectomy systems, neurovascular embolization coiling systems, neurovascular access systems, neurosurgical aspiration tools, detachable embolic coil systems, microcatheters, occlusion devices, and immersive computer-based technologies. Penumbra generates revenue through the sale of its medical devices, which are used in various neurovascular and vascular therapies, and are distributed through direct sales organizations and distributors.